دورية أكاديمية

Influence of splenectomy in patients with liver cirrhosis and hypersplenism.

التفاصيل البيبلوغرافية
العنوان: Influence of splenectomy in patients with liver cirrhosis and hypersplenism.
المؤلفون: Nomura, Yoriko, Kage, Masayoshi, Ogata, Toshirou, Kondou, Reiichirou, Kinoshita, Hisafumi, Ohshima, Kouichi, Yano, Hirohisa
المصدر: Hepatology Research; Oct2014, Vol. 44 Issue 10, pE100-E109, 10p
مصطلحات موضوعية: CIRRHOSIS of the liver, SPLENECTOMY, HYPERSPLENISM, IMMUNOHISTOCHEMISTRY, THROMBOCYTOPENIA, ANTINEOPLASTIC agents, LYMPHOCYTES
مستخلص: Aim Splenectomy improves hypersplenic thrombocytopenia in cirrhotic patients with hypersplenism. However, the long-term influence of splenectomy has not been clarified. We examined whether splenectomy improved liver fibrosis and caused immunological changes. Methods We collected liver and spleen specimens and peripheral blood ( PB) from 26 patients with hepatitis C virus-related liver cirrhosis. An immunohistochemical examination of CD4, CD8, forkhead box P3, granzyme B and transforming growth factor-β1, and Masson-trichrome stain were performed in spleen and liver tissues and in seven cases of follow-up liver biopsy sections obtained after splenectomy. We obtained PB before and at various intervals after splenectomy. We also examined the ratio of CD4+ and CD8+ lymphocytes in PB using flow cytometry. Results We observed improvements in liver fibrosis in four biopsy specimens obtained after splenectomy, in which fibrotic areas significantly decreased from 19.5% to 8.2% ( P < 0.05). Increases were also observed in the ratio of CD8+ cells in PB after splenectomy, which resulted in a significant decrease in the CD4+/ CD8+ ratio ( P < 0.001). The carcinogenic rate in patients with a CD4+ : CD8+ ratio that decreased by more than 0.5 at 1 month after splenectomy was significantly lower than that in patients with a ratio that decreased by less than 0.5 ( P < 0.05). Conclusion Splenectomy may improve liver fibrosis and cause beneficial immunological changes in cirrhotic patients with hepatitis. Improvements in antitumor mechanisms can be also expected. [ABSTRACT FROM AUTHOR]
Copyright of Hepatology Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:13866346
DOI:10.1111/hepr.12234